 |
|
|
| |
Pharmacokinetics, Safety and Antiviral Activity of Fosamprenavir/Ritonavir-Containing Regimens in HIV-Infected 4 Weeks to <2-Year-Old Children 48-Week Data From Study APV20002
|
| |
| |
Reported by Jules Levin
19th International AIDS Conference
July 22-27, 2012; Washington, DC
M Cotton, H Cassim, N Pavia-Ruz, L Ross, S Ford, N Givens, K Cheng, J Sievers
|
| |
|
|
|
|
|
